Company performance
Current Price
as of Jun 18, 2025$194.44
P/E Ratio
37.70
Market Cap
$139.15B
Description
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Metrics
Overview
- HQWashington, DC
- SectorHealth Technology
- IndustryMedical Specialties
- TickerDHR
- Price$194.44-0.67%
Trading Information
- Market cap$139.15B
- Float91.13%
- Average Daily Volume (1m)3,570,938
- Average Daily Volume (3m)4,083,821
- EPS$5.20
Company
- Revenue$23.82B
- Rev growth (1yr)-0.95%
- Net income$954.00M
- Gross margin61.42%
- EBITDA margin32.75%
- EBITDA$1.88B
- EV$163.97B
- EV/Revenue6.88
- P/E37.70
- P/S5.88
- P/B2.74
- Debt/Equity34.57